No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SABS SAB Biotherapeutics
- 2.8600
- -0.1800-5.92%
Close Jul 2 16:00 ET
26.40MMarket Cap-425P/E (TTM)
3.0300High2.8400Low7.33KVolume2.9800Open3.0400Pre Close21.27KTurnover0.13%Turnover RatioLossP/E (Static)9.23MShares10.500052wk High0.50P/B16.69MFloat Cap2.360052wk Low--Dividend TTM5.84MShs Float129.0000Historical High--Div YieldTTM6.25%Amplitude2.3600Historical Low2.9000Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersTempest Therapeutics (NASDAQ:TPST) shares rose 32.8% to $3.79 during Thursday's pre-market session. The company's market cap stands at $84.0 million. Neurogene (NASDAQ:NGNE) shares rose 31.92%
Express News | SAB Biotherapeutics Inc: Rebrands as SAB Bio
Express News | SAB Biotherapeutics Inc: Confirmed Its Outlook for Fiscal Year 2024
SAb Biotherapeutics Rebrands as SAB BIO
New name, logo and website updates, stock symbol will remain SABS With new brand identity, SAB BIO continues drive towards serious unmet needs in type 1 diabetes MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- SAB
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersNexalin Technology (NASDAQ:NXL) stock increased by 48.1% to $1.54 during Wednesday's after-market session. The company's market cap stands at $11.4 million. Tempest Therapeutics (NASDAQ:TPST) s
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersNexalin Technology (NASDAQ:NXL) shares rose 55.8% to $1.62 during Tuesday's after-market session. The market value of their outstanding shares is at $12.0 million. Dynatronics (NASDAQ:DYNT) sto
Comments
$SAB Biotherapeutics(SABS.US$ Reuters· just
FDA Provides Clearance to Ind Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
FDA Provides Clearance to Ind Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
$SAB Biotherapeutics(SABS.US$
NEWS
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
SAB Biotherapeutics (Nasdaq: SABS) announced that the FDA has cleared its IND application for SAB-142, a type 1 diabetes therapy, to proceed to a Phase 1 clinical trial in the US.
SAB-142, a human anti-thymocyte immunoglobulin (hIgG), aims to delay the onset or progression of type 1 diabetes. The ongoing HUMAN trial will assess the safety, tolerability, pharmac...
NEWS
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
SAB Biotherapeutics (Nasdaq: SABS) announced that the FDA has cleared its IND application for SAB-142, a type 1 diabetes therapy, to proceed to a Phase 1 clinical trial in the US.
SAB-142, a human anti-thymocyte immunoglobulin (hIgG), aims to delay the onset or progression of type 1 diabetes. The ongoing HUMAN trial will assess the safety, tolerability, pharmac...
$SAB Biotherapeutics(SABS.US$ SAB-142 In addition to the currently approved and ongoing Phase 1, there is plans to bring this program to IND and CTA filings with global regulatory authorities by the mid-2024. As there are unmet medical needs globally for disease-modifying treatments of T1D, they are going to work with global health authorities and file clinical trial applications and clinical trial notifications in other countries to have a global footprint and reach patients with T1D wor...
1
4/17/24 Watchlist 📊⚡️📊⚡️📊⚡️📊
$BYND Cannasoft(BCAN.US$ $SAB Biotherapeutics(SABS.US$ $Macatawa Bank(MCBC.US$ $Dragonfly Energy(DFLI.US$ $My Size(MYSZ.US$ $SoundHound AI(SOUN.US$ $ARK 21Shares Bitcoin ETF(ARKB.US$
📊⚡️📊 #stock_drift24
⭐️just a watchlist, not financisl advice⭐️
$BYND Cannasoft(BCAN.US$ $SAB Biotherapeutics(SABS.US$ $Macatawa Bank(MCBC.US$ $Dragonfly Energy(DFLI.US$ $My Size(MYSZ.US$ $SoundHound AI(SOUN.US$ $ARK 21Shares Bitcoin ETF(ARKB.US$
📊⚡️📊 #stock_drift24
⭐️just a watchlist, not financisl advice⭐️
3
1
$SAB Biotherapeutics(SABS.US$ SAB Biotherapeutics' Has Completed Dosing The Third Cohort For Phase 1 Study Of SAB-142 In Healthy Volunteers And Participants With Type 1 Diabetes With No Observation Of Serum Sickness Thus Far
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg